Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFITM3 antisense RNA 1 (IFITM3-AS1) is a long non-coding RNA gene transcribed in the antisense direction relative to the IFITM3 gene, which encodes interferon-induced transmembrane protein 3 (IFITM3). Unlike its protein-coding counterpart, IFITM3-AS1 is not translated into a protein and instead is thought to participate in the regulation of gene expression, potentially through antisense-mediated modulation of IFITM3 or nearby genomic elements. Long non-coding RNAs such as IFITM3-AS1 are increasingly recognized for their roles in epigenetic and transcriptional regulation but are not classical therapeutic targets like receptors or enzymes. Currently, there is limited published information on disease-specific roles, functional characterization, or targeting strategies for IFITM3-AS1. Additional relevant context: - The protein-coding IFITM3 gene encodes a small transmembrane protein that plays a significant role in host antiviral defense; however, this is distinct from the non-coding antisense RNA IFITM3-AS1. - Long non-coding RNAs like IFITM3-AS1 are studied for their potential as diagnostic or prognostic markers, but no established clinical use is reported for this gene. If you seek information on the protein-coding IFITM3 target, please clarify, as it is functionally distinct and widely studied in antiviral immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IFITM3 antisense RNA 1 (IFITM3-AS1).